pI: 6.4905 |
Length (AA): 310 |
MW (Da): 35330 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 7 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
35 | 310 | 1tpy (A) | 3 | 276 | 14.00 | 0 | 1 | 0.91 | -0.36 |
38 | 301 | 1tpy (A) | 6 | 275 | 15.00 | 0 | 1 | 1.05 | -0.55 |
85 | 255 | 1vl5 (A) | 34 | 199 | 22.00 | 0 | 1 | 0.89 | -0.63 |
13 | 296 | 3vc1 (A) | 16 | 286 | 19.00 | 0 | 1 | 1.16143 | -0.15 |
83 | 273 | 3bkw (A) | 30 | 242 | 21.00 | 0.000000000025 | 1 | 0.805429 | -0.49 |
88 | 213 | 1l3i (A) | 28 | 149 | 16.00 | 0.00086 | 0.29 | 0.670752 | -1.15 |
88 | 155 | 3gcz (A) | 68 | 135 | 38.00 | 0.23 | 0.08 | 0.352655 | 0.48 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_129172)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G76090 | 24-methylenesterol C-methyltransferase 3 |
Arabidopsis thaliana | AT1G20330 | 24-methylenesterol C-methyltransferase 2 |
Arabidopsis thaliana | AT5G13710 | cycloartenol-c-24-methyltransferase |
Brugia malayi | Bm1_45250 | S-adenosyl-methionine cycloartenol-C24-methyltransferase |
Candida albicans | CaO19.9199 | SAM:delta 24-methyltransferase involved in ergosterol biosynthesis |
Candida albicans | CaO19.1631 | SAM:delta 24-methyltransferase involved in ergosterol biosynthesis |
Caenorhabditis elegans | CELE_H14E04.1 | Protein H14E04.1 |
Dictyostelium discoideum | DDB_G0288907 | hypothetical protein |
Leishmania braziliensis | LbrM.35.2600 | sterol 24-c-methyltransferase, putative |
Leishmania donovani | LdBPK_362510.1 | sterol 24-c-methyltransferase, putative |
Leishmania infantum | LinJ.36.2520 | sterol 24-c-methyltransferase, putative |
Leishmania infantum | LinJ.36.2510 | sterol 24-c-methyltransferase, putative |
Leishmania major | LmjF.36.2380 | sterol 24-c-methyltransferase, putative |
Leishmania major | LmjF.36.2390 | sterol 24-c-methyltransferase, putative |
Leishmania mexicana | LmxM.36.2390 | sterol 24-c-methyltransferase, putative |
Leishmania mexicana | LmxM.36.2380 | sterol 24-c-methyltransferase, putative |
Loa Loa (eye worm) | LOAG_00971 | hypothetical protein |
Oryza sativa | 9269350 | Os03g0807600 |
Oryza sativa | 4331540 | Os03g0136200 |
Oryza sativa | 4342690 | Os07g0206700 |
Saccharomyces cerevisiae | YML008C | sterol 24-C-methyltransferase |
Trypanosoma brucei gambiense | Tbg972.10.8450 | sterol 24-c-methyltransferase, putative |
Trypanosoma brucei | Tb927.10.6910 | Sterol methyltransferase, putative |
Trypanosoma brucei | Tb11.v5.0496 | sterol 24-c-methyltransferase, putative |
Trypanosoma brucei | Tb927.10.6950 | sterol 24-c-methyltransferase, putative |
Trypanosoma cruzi | TcCLB.505683.10 | sterol 24-c-methyltransferase, putative |
Trypanosoma cruzi | TcCLB.504191.10 | sterol 24-c-methyltransferase, putative |
Trypanosoma cruzi | TcCLB.510185.10 | sterol 24-c-methyltransferase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.6950 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.6950 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.6950 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.6950 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
growth (GO:0040007) | decreased (PATO:0000468) | amastigote (BTO:0000062) | inferred from in vitro culture assay (ECO:0000182) | Trypanosoma cruzi | 912702 | |
Annotator: | millerja@u.washington.edu. | Comment: | See Table 2 in referenced publication for structure of Compound 3a. | References: | 15273104 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.6
Compound | Source | Reference |
---|---|---|
Curated by TDRTargets | References |
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Glycine max | S-adenosyl-L-methionine:delta24-sterol-C-methyltransferase | Compounds | References |
Trypanosoma cruzi | sterol 24-c-methyltransferase, putative | Compounds | References |
Trypanosoma cruzi | sterol 24-c-methyltransferase, putative | Compounds | References |
Arabidopsis thaliana | cycloartenol-c-24-methyltransferase | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Trypanosoma cruzi | sterol 24-c-methyltransferase, putative | 161 aa | 100.0% | 150 aa | Compounds | References |
11 literature references were collected for this gene.